Active Pharmaceutical Ingredient Blending

Conduct Research

• Handling Highly Active Ingredients
  that offered containment levels between those of gloveboxes and those of cleanrooms, at costs approaching those of cleanrooms. The term for the equipment was questionable at best, since barriers and isolators do. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical...
• Handling Highly Active Ingredients
  operation to the next, and, most interestingly, through flexible-film mini-enclosures that minimize cleaning and related validation. System designs reflect increased a focus on meeting occupational exposure. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical...
• Handling Highly Active Ingredients
  Durney, director for new business development at ILC Dover (Frederica, Del.), claims the cost savings from disposable PPE alone more than offsets the. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical Manufacturing. Digital Magazine: Read / Subscribe. RSS...
• Introducing PAT, Using NIR Analysis, to a Pharmaceutical Blending Process
  determination involve sampling of the blend using a sample thief and laboratory analysis of the samples using chemical methods . In addition, blend uniformity in the traditional sense focuses on the distribution of the active pharmaceutical ingredient in the blend as opposed to distribution...
• IFPAC Conference Highlights Pharmaceutical Applications of PAT
  . Laurie St. Pierre Berry, PAT specialist at Pfizer's Groton, Conn., plant described her company's use of NIR as well as infrared (IR) and reduction-oxidation techniques. "New PAT strategies are being implemented into API [active pharmaceutical ingredient] facilities for controlling and monitoring...
• Achieving Operational Excellence in Pharmaceutical Manufacturing (.pdf)
  for the multi-billion dollar Western global. milling, compacting, coating and even some packaging is still. drug corporations. manual in nature. It still requires a human to weigh out a given. amount of Active Pharmaceutical Ingredient (API); people still. Initiatives such as Process Analytical...
• Introducing PAT, Using NIR Analysis, to a Pharmaceutical Blending Process
  uniformity in the “traditional sense” focuses on the distribution of the active pharmaceutical ingredient in the blend as opposed to distribution of the excipients in the blend, which can influence the desired performance of the pharmaceutical product2.Magnesium stearate is a commonly used tablet...
• Powder Blending From Art to Science
  ingredients when fluctuations occur. K-Tron s feeders also use a pneumatic vacuum receiver to feed the delivery hopper continuously. Additional feedback is provided by process analytics at the output end. Although batch blending will dominate for the foreseeable future, pharmaceutical manufacturers...
• Using MEMS to Control Blending at AstraZeneca
  By Peter J. Brush, Ph.D., and Albert W. Alexander, Ph.D., both senior scientists at AstraZeneca Pharmaceuticals Blending of active pharmaceutical ingredients (APIs) with various excipients is a common step in the pharmaceutical solid dosage form manufacturing process. The homogeneity of the blend...
• Powder Blending From Art to Science
  This quick, one-time registration gives you access to members-only site benefits. Dry powder blending may be the most widely recognized unit operation in pharmaceutical manufacturing, but it s also one of the least understood. The uniqueness of each individual drug formulation assures that no two...

Engineering Web Search: Active Pharmaceutical Ingredient Blending